Arbonia AG (0QKR)
London Exchange · UK · prices in GBP · close of 22 Oct 2026
Key indicators
| Last close | GBP 4.380 |
|---|---|
| 52-week range | 3.500 – 5.725 |
| Return, 1 month / 3 months | −7.8% / +21.2% |
| Return, 1 year / 3 years | −14.8% / −40.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 39 |
| Volatility (1 year) | 39.9% |
| Worst drawdown (1 year) | -38.7% |
| Average daily value traded | 0.09M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Arbonia AG is a Swiss manufacturer of building components based in Arbon. The company makes doors and windows as well as heating, ventilation and climate products for residential and commercial buildings. Its customers are mainly in the construction and renovation trade, including builders, installers and property developers, and its markets are concentrated in Europe. Arbonia supplies both new-build projects and refurbishment work, offering interior and exterior fittings that go into homes, offices and other buildings.
On this site Arbonia AG appears as a stock on the London Exchange (UK), code 0QKR, with prices in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Arbonia AG (0QKR) trades on the London Exchange in UK. It last closed at GBP 4.380 on 22 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 2,300 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.8% and over the last three months it rose 21.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.9% | ||
| From 52-week high | -23.5% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 21.2% | ||
| 6-month return | 4.0% | ||
| 12-month return, skipping the last month | -7.6% | ||
| Stability (higher is calmer) | 37 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.7% | ||
| Liquidity | 28 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.09M GBP | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.7% |
|---|---|
| 1 month | −7.8% |
| 3 months | +21.2% |
| 6 months | +4.0% |
| 1 year | −14.8% |
| 3 years | −40.8% |
| 5 years | −78.8% |
Signals
| 50-day / 200-day average | 4.472 / 4.340 |
|---|---|
| Golden / death cross (60 days) | Golden, 7 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.099 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Apr 2025 | GBX 0.0017 |
| 25 Apr 2023 | GBX 0.0015 |
| 26 Apr 2022 | GBX 0.0015 |
| 27 Apr 2021 | GBX 0.0024 |
| 16 Apr 2019 | GBX 0.0020 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.